Robert Smith
Net worth: - $ as of 2026-05-30
Net worth: - $ as of 2026-05-30
Mr. Robert J.
Smith is an Independent Director at Citius Oncology, Inc. and an Independent Director at Citius Pharmaceuticals, Inc. He is on the Board of Directors at Citius Oncology, Inc., Citius Pharmaceuticals, Inc., Foundation For Cell & Gene Medicine and Alliance for Regenerative Medicine.
Mr. Smith was previously employed as a Senior Vice President-Global Gene Therapy Business by Pfizer Inc. and a Senior Vice President-Mergers & Acquisitions by Wyeth LLC.
He also served on the board at BioNJ, Inc., Life Sciences Pennsylvania, Ignite Immunotherapy, Inc. and Bamboo Therapeutics, Inc. He received his undergraduate degree from the University of Rochester and an MBA from the University of Rochester Simon Business School.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
-.--% | 2026-05-21 | 0 ( -.--% ) | - $ | 2026-05-30 |
| 2026-02-12 | 0 ( -.--% ) | - $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| CITIUS PHARMACEUTICALS, INC. | Director/Board Member | 2024-03-11 |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Director/Board Member | 2017-12-31 |
Foundation For Cell & Gene Medicine | Director/Board Member | 2018-12-31 |
| Companies | Position | End |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 2023-12-31 |
Ignite Immunotherapy, Inc.
Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Designs and develops oncolytic virus vaccines | Director/Board Member | 2019-09-30 |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops gene therapies for rare neuromuscular and central nervous system diseases | Director/Board Member | 2016-07-31 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Corporate Officer/Principal | 2009-09-30 |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Operates as a pharmaceutical company | Health Technology |
Life Sciences Pennsylvania
Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Provides consulting services to biosciences industry | Commercial Services |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
University of Rochester Simon Business School
University of Rochester Simon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops gene therapies for rare neuromuscular and central nervous system diseases | Health Technology |
Ignite Immunotherapy, Inc.
Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Designs and develops oncolytic virus vaccines | Health Technology |
Foundation For Cell & Gene Medicine |
Select your edition
All financial news and data tailored to specific country editions